Metoprolol Tartrate to Succinate Conversion
When converting from metoprolol tartrate to metoprolol succinate, use a 1:1 dose conversion ratio, where 100 mg of metoprolol tartrate (given twice daily) equals 100 mg of metoprolol succinate (given once daily). 1
Dosage Equivalence
- Metoprolol tartrate is typically administered twice daily (BID), while metoprolol succinate (XL/ER) is administered once daily (QD) 1
- A 100 mg metoprolol succinate extended-release tablet contains 95 mg of metoprolol succinate and is considered therapeutically equivalent to 100 mg of metoprolol tartrate 2
- Common dosing ranges:
Pharmacological Differences
- Metoprolol succinate uses a controlled release/extended-release formulation designed to provide relatively constant plasma concentrations over approximately 20 hours 2
- After ingestion, the metoprolol succinate tablet disintegrates into individual pellets with each pellet acting as a diffusion cell releasing the drug at a relatively constant rate 2
- Both formulations produce similar hemodynamic and clinical effects despite different dosing schedules 3
Clinical Considerations for Conversion
When transitioning from tartrate to succinate in patients with cardiovascular conditions:
In post-MI or heart failure patients, a gradual transition over 2-3 days from metoprolol tartrate to succinate is recommended to ensure stable blood levels 1
Special Considerations
Metoprolol succinate may offer advantages over tartrate in certain clinical scenarios:
Common pitfalls to avoid:
- Ensure patients understand the change in dosing frequency (from twice daily to once daily) to prevent medication errors 1
- Monitor for adequate blood pressure and heart rate control during the transition period 1
- Be aware that metoprolol succinate is sometimes available in higher single doses than tartrate (up to 400 mg) 1